Get the Stockscreener App
4.89
0.20%
-0.01
After Hours:
4.98
0.09
+1.84%
Mei Pharma Inc stock is traded at $4.89, with a volume of 565.31K.
It is down -0.20% in the last 24 hours and up +59.28% over the past month.
MEI Pharma Inc is focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical development portfolio also includes Zandelisib, an oral inhibitor of phosphatidylinositide 3-kinase delta for the treatment of patients with recurrent chronic lymphocytic leukemia or follicular non-Hodgkin's lymphoma; and ME-344, an isoflavone-based mitochondrial inhibitor for the treatment of HER2-negative breast cancer and Pracinostat, an oral histone deacetylase inhibitor. Geographically, all the business activities function through the region of the United States.
See More
Previous Close:
$4.90
Open:
$4.96
24h Volume:
565.31K
Relative Volume:
0.58
Market Cap:
$158.28M
Revenue:
$105.38M
Net Income/Loss:
$17.78M
P/E Ratio:
1.8315
EPS:
2.67
Net Cash Flow:
$-50.48M
1W Performance:
-5.78%
1M Performance:
+59.28%
6M Performance:
+81.78%
1Y Performance:
+54.26%
1-Day Range:
$4.73
$5.065
1-Week Range:
$4.62
$5.5477
52-Week Range:
$1.46
$9.00
Mei Pharma Inc Stock (MEIP) Company Profile
Name
Mei Pharma Inc
Sector
Industry
Phone
858-369-7100
Address
11455 EL CAMINO REAL, SAN DIEGO, CA
Compare MEIP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MEIP
Mei Pharma Inc
|
4.89 | 158.60M | 105.38M | 17.78M | -50.48M | 2.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Mei Pharma Inc Stock (MEIP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-23-24 | Downgrade | Laidlaw | Buy → Hold |
| Mar-25-22 | Downgrade | Jefferies | Buy → Hold |
| Mar-25-22 | Downgrade | Stifel | Buy → Hold |
| Mar-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-03-22 | Initiated | Jefferies | Buy |
| Sep-22-20 | Initiated | Alliance Global Partners | Buy |
| May-29-20 | Initiated | SunTrust | Buy |
| Dec-20-18 | Initiated | H.C. Wainwright | Buy |
| Jul-27-18 | Upgrade | Stifel | Hold → Buy |
| Jul-13-18 | Initiated | SunTrust | Buy |
| Apr-18-16 | Reiterated | Wedbush | Neutral |
| Mar-23-15 | Downgrade | ROTH Capital | Buy → Neutral |
| Dec-18-14 | Reiterated | ROTH Capital | Buy |
| Oct-16-14 | Reiterated | ROTH Capital | Buy |
| Jul-08-14 | Resumed | Brean Capital | Buy |
| Oct-22-13 | Reiterated | Stifel | Buy |
| Apr-15-13 | Initiated | Stifel | Buy |
View All
Mei Pharma Inc Stock (MEIP) Latest News
Can MEI Pharma Inc. deliver alphaJuly 2025 Review & High Win Rate Trade Alerts - thegnnews.com
Chart overlay techniques for tracking MEI Pharma Inc.CPI Data & Accurate Technical Buy Alerts - Newser
How to read the order book for MEI Pharma Inc.July 2025 Breakouts & Long Hold Capital Preservation Plans - Newser
Institutional scanner results for MEI Pharma Inc.Market Risk Report & Reliable Trade Execution Plans - Newser
Measuring MEI Pharma Inc.’s beta against major indicesChart Signals & Comprehensive Market Scan Reports - Newser
Strategies to average down on MEI Pharma Inc.Quarterly Trade Summary & Weekly Consistent Profit Watchlists - Newser
Pattern recognition hints at MEI Pharma Inc. upsideJuly 2025 Market Mood & Stepwise Swing Trade Plans - Newser
Volume spikes in MEI Pharma Inc. stock – what they meanIndex Update & AI Enhanced Trading Alerts - Newser
How to manage a losing position in MEI Pharma Inc.Alpha Stock Picks with Chart Confirmation - Newser
Litecoin Surges 24% as MEI Pharma Boosts Treasury with $100M Investment - AInvest
Evaluating MEI Pharma Inc. with trendline analysisReal Time Stock Movement and Alerts - Newser
Is it too late to sell MEI Pharma Inc.AI Enhanced Strategy for Portfolio Growth - Newser
Combining machine learning predictions for MEI Pharma Inc.AI Screener for Daily Stock Forecast - Newser
Litecoin Hits Five-Month High on ETF Hype and MEI Pharma Treasury Deal - AInvest
Will MEI Pharma Inc. stock benefit from AI tech trendsDaily Market Movers Screener with Filters - Newser
What Fibonacci levels say about MEI Pharma Inc. reboundConservative Investment Setup and Risk Analysis - Newser
How to monitor MEI Pharma Inc. with trend dashboardsAI Volatility Forecast and Risk Monitor - Newser
What’s the analyst consensus on MEI Pharma Inc.Trade Picks with 3x Upside - sisain.net
Technical analysis overview for MEI Pharma Inc. stockTrade Ideas Based on Fundamental Metrics - Newser
How to escape a deep drawdown in MEI Pharma Inc.Fast Return Equity Forecast With Logic - Newser
How MEI Pharma Inc. stock performs during market volatilityWeekly Trend Watch with Market Signals - Newser
Can MEI Pharma Inc. stock recover from recent declineTechnical Setup Guide for Daily Watchlist - Newser
MEI Pharma Welcomes New Board Member Joshua Riezman - TipRanks
Bitcoin News Today: MEI Pharma Invests $100M in Litecoin as Treasury Diversification Strategy - AInvest
Ethereum News Today: MEI Pharma Allocates $100M to Litecoin in Bold Treasury Shift - AInvest
Can machine learning forecast MEI Pharma Inc. recoveryFree AI Driven Stock Trend Forecast - Newser
Litecoin's Institutional Leap: MEI Pharma Adopts LTC as a Reserve Asset Amid ETF Buzz - OKX
Litecoin Soars as MEI Pharma Launches $100M Institutional Treasury StrategyFinanceSecond - financesecond.com
MEI Pharma Kicks Off Its Litecoin-Focused Digital Asset Treasury with $110M Purchase - NFTgators
MEI Pharma’s Crypto Treasury Move: 930,000 Litecoin Tokens Acquired - Bitcoin.com News
Bitcoin News Today: MEI Pharma Allocates $100M to Litecoin as Core Treasury Asset - AInvest
MEI Pharma Chooses Not Bitcoin, Not Ethereum, But Litecoin As Treasury Asset - Benzinga
MEI Pharma Launches $110 Million Litecoin Treasury Strategy - CoinCentral
MEI Pharma's Litecoin treasury purchase sets off LTC rally - Mitrade
Ethereum News Today: MEI Pharma Allocates $100M to Litecoin as Primary Treasury Asset with GSR and Charlie Lee - AInvest
Litecoin Hits Five-Month High on ETF Optimism and $100M MEI Pharma Investment - AInvest
Litecoin Hits Five-Month High Amid ETF Optimism and $100M MEI Pharma Treasury - Yahoo Finance
Mei Pharma acquires Litecoin, launches $100m institutional treasury strategy - MarketScreener
MEI Pharma Acquires Litecoin as Primary Reserve Asset - TipRanks
MEI Pharma acquires $100 million in Litecoin for treasury strategy - Investing.com
MEI Pharma acquires $100 million in Litecoin for treasury strategy By Investing.com - Investing.com Nigeria
MEI Pharma Invests in Litecoin as Primary Treasury Asset - San Diego Business Journal
Mei Pharma Inc Stock (MEIP) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.41%
0.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):